A review on prognostic biomarker and phytocompound-mediated modulation of signaling pathways in colorectal cancer.

Key Points

• The aim is to examine the role of prognostic biomarkers and phytocompound therapies in colorectal cancer (CRC) treatment.
• Review of existing literature on biomarkers and phytocompounds
• Analysis of signaling pathways involved in CRC
• Evaluation of drug delivery methods and multi-omics strategies
• Phytocompounds show promise in modulating cancer-related signaling pathways
• Biomarker profiling can enhance treatment accuracy and reduce side effects
• Further clinical validation and integration of multi-omics are necessary for advancing CRC therapy.

Abstract